Cargando…
Estimation of Equipotent Doses for Anti‐Inflammatory Effects of Prednisolone and AZD9567, an Oral Selective Nonsteroidal Glucocorticoid Receptor Modulator
AZD9567 is a potent and selective nonsteroidal oral glucocorticoid receptor modulator. It is developed as an anti‐inflammatory drug with improved safety profile compared with steroids like prednisolone. Throughout the clinical development of AZD9567, dose selection and data interpretation require a...
Autores principales: | Almquist, Joachim, Sadiq, Muhammad Waqas, Eriksson, Ulf G., Hegelund Myrbäck, Tove, Prothon, Susanne, Leander, Jacob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438818/ https://www.ncbi.nlm.nih.gov/pubmed/32501650 http://dx.doi.org/10.1002/psp4.12536 |
Ejemplares similares
-
Safety, Pharmacokinetics and Pharmacodynamics of the Selective Glucocorticoid Receptor Modulator Velsecorat (AZD7594) Following Inhalation in Healthy Volunteers
por: Prothon, Susanne, et al.
Publicado: (2022) -
Safety, pharmacokinetics and pharmacodynamics of the selective glucocorticoid receptor modulator AZD7594, following inhalation in healthy Japanese volunteers
por: Prothon, Susanne, et al.
Publicado: (2019) -
Comparison of equipotent doses of rocuronium and vecuronium
por: Parasa, Mrunalini, et al.
Publicado: (2015) -
The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial
por: Patel, Naimish R, et al.
Publicado: (2018) -
Gene expression analysis of membrane transporters and drug-metabolizing enzymes in the lung of healthy and COPD subjects
por: Berg, Tove, et al.
Publicado: (2014)